Full Text
PDB22 SELF-MONITORING OF BLOOD GLUCOSE (SMBG) FOR TYPE 2 DIABETES PATIENTS ON ORAL ANTI-DIABETES DRUGS (OADS)- COST-EFFECTIVENESS IN FRANCE, GERMANY, AND SPAIN

Abstract

Authors

S Tunis WD Willis

Back to Volume 12, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×